Adverse events · patients with chronic pancreatitis and pancreatic pain
Pregabalin probably leads to higher adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events · patients with chronic pancreatitis and pancreatic pain
Pregabalin showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events · adults with fibromyalgia enrolled in EERW studies
1 finding from 1 review
Serious adverse events · adults with fibromyalgia
1 finding from 1 review
Adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
Withdrawals due to adverse events · adults with fibromyalgia
1 finding from 1 review
Withdrawals due to adverse events · people with drug‐resistant focal epilepsy
1 finding from 1 review
Serious adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
Serious adverse events · patients with fibromyalgia
Pregabalin showed no clear difference in serious adverse events compared with placebo at end of treatment (moderate certainty).
1 finding from 1 review
Adverse effects: drowsiness (gabapentin alone) · people with postburn pruritus
Pregabalin may leads to lower adverse events (drowsiness) compared with cetirizine with pheniramine maleate (antihistamine) (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with fibromyalgia
Pregabalin leads to higher withdrawal due to adverse events compared with placebo at end of treatment (high certainty).
1 finding from 1 review
Withdrawals due to adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review